CHIOME BIOSCIENCE
Chiome Bioscience was established in 2005 to commercialize the innovative ADLib® antibody generation technology invented at RIKEN. Since that time the Company has worked on research and development for this system, as well as initiatives for technology licensing. It focused mainly on joint research and contract research with the research arms of pharmaceutical companies and academia. Meanwhile, in 2011 the Company was listed on the Mothers market of the Tokyo Stock Exchange, and in 2015 it merg... ed with LivTech which focused on drug discovery and development of therapeutic antibody for oncology, thus adding drug discovery function. In 2017 the Company went through reorganization of the management team, switching its strategy from platform development to drug discovery and development. At the same time it started setting up the clinical function which enables us to run a clinical study aiming of significant increase in corporate value.
CHIOME BIOSCIENCE
Industry:
Biotechnology Health Care
Founded:
2005-02-08
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.chiome.co.jp
Total Employee:
11+
Status:
Active
Contact:
+81-3-6383-3561
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Apache
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
M&B Sciences
M&B Sciences is a fast-growing African-American-owned, technology-driven clinical research organization.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-03-16 | LivTech | LivTech acquired by Chiome Bioscience | N/A |
Investors List
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Funding Round - Chiome Bioscience
Official Site Inspections
http://www.chiome.co.jp Semrush global rank: 2.49 M Semrush visits lastest month: 7.09 K
- Host name: chiome.co.jp
- IP address: 202.229.135.157
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Chiome Bioscience"
IR情報│業績・財務情報│株式会社カイオム・バイオサイエンス
An introduction to Chiome Bioscience’s antibody technology platform including our proprietary ADLib ® system. Pipeline パイプライン 当社が開発するパイプラインの進捗状況や詳細をご確 …See details»
Chiome Bioscience - Crunchbase Company Profile & Funding
Chiome Bioscience was established in 2005 to commercialize the innovative ADLib® antibody generation technology invented at RIKEN. Since that time the Company has worked on …See details»
Chiome Bioscience - Overview, News & Similar companies
Chiome Bioscience contact info: Phone number: +81 363833561 Website: www.chiome.co.jp What does Chiome Bioscience do? Chiome Bioscience is a clinical stage biotechnology …See details»
Chiome Bioscience Company Profile - Office Locations ... - Craft
Oct 11, 2024 Chiome Bioscience has 3 employees across 2 locations and ¥682.46 m in annual revenue in FY 2023. See insights on Chiome Bioscience including office locations, …See details»
Chiome Bioscience and Asahi Kasei Pharma Enter into Exclusive …
November 20, 2024 Chiome Bioscience Inc. Asahi Kasei Pharma Corp. Chiome Bioscience Inc. (Head office: Shibuya, Tokyo; President: Shigeru Kobayashi; hereinafter “Chiome”) and Asahi …See details»
Chiome Bioscience - PitchBook
Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of …See details»
Chiome Bioscience Company Description - Stock Analysis
Nov 22, 2024 Company profile for Chiome Bioscience Inc. (TYO: 4583) with a description, list of executives, contact details and other key facts.See details»
Chiome Bioscience, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Chiome Bioscience, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 1 news, and 19 literature, Disease Domain:Neoplasms, Immune System …See details»
CHIOME BIOSCIENCE INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CHIOME BIOSCIENCE INC. of KAWASAKI, KANAGAWA. Get the latest business insights from Dun & …See details»
Company Chiome Bioscience Inc. - MarketScreener.com
Jun 30, 2010 Chiome Bioscience Inc. is a company mainly engaged in the research and development of antibody drugs, and the provision of development support services. The …See details»
Business alliance agreement for co-development of biosimilars
Jun 18, 2024 President & CEO Shinya Kurebayashi and Chiome Bioscience Inc. (hereinafter “Chiome”), headquartered in Tokyo, Japan and led by President & CEO Shigeru Kobayashi …See details»
Chiome Bioscience CEO and Key Executive Team | Craft.co
Chiome Bioscience's President, Chief Executive Officer is Shigeru Kobayashi. Other executives include Arihiko Bijohira, Executive Director, Chief Financial Officer, Head of Corporate …See details»
Chiome Bioscience Inc, 4583:TYO profile - FT.com - Financial Times
Nov 25, 2024 Chiome Bioscience Inc. is a company mainly engaged in the research and development of antibody drugs, and the provision of development support services. The …See details»
[Revised] Chiome Announces Exclusive Licensing Agreement for …
Company: Chiome Bioscience Inc. Representative: Shigeru Kobayashi, President & CEO (Code: 4583, Tokyo Stock Exchange Growth) [Revised] Chiome Announces Exclusive Licensing …See details»
Chiome Bioscience Inc. Company Information - Simply Wall St
Learn more about Chiome Bioscience Inc. (4583). ... https://www.chiome.co.jp; Number of Employees. Location. Chiome Bioscience Inc. Sumitomo Fudosan Nishi-shinjuku Bldg.No.6 ...See details»
Chiome Bioscience - Company Information, Competitors, News
The official website of Chiome Bioscience is chiome.co.jp You can find their contact number, email address, and headquarters by clicking here. How many employees are working at …See details»
Inside information pursuant to Article 17 MAR Heidelberg Pharma …
Jul 13, 2022 Chiome has proprietary antibody generating technology named ADLib® a System and several antibody discovery and preclinical programs. ... (code: 4583), and located in …See details»
Kidswell Bio, Chiome Hook Up on Biosimilar Development
Jun 19, 2024 Kidswell Bio and Chiome Bioscience said on June 18 that they have formed a business alliance for the joint development of biosimilars. The two Tokyo firms hope to draw …See details»
ADLib Antibody Generation Service Workflow (Basic Plan) - CHIOME
Copyright © 2024 Chiome Bioscience Inc. All Rights Reserved. STEP3 Sequence analysis of variable regions & clone grouping STEP4 Preparation of DT40See details»